TD Cowen analyst Brendan Smith maintained a Buy rating on Passage Bio (PASG – Research Report) today. The company’s shares opened ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback